León Litwak

876 total citations
37 papers, 642 citations indexed

About

León Litwak is a scholar working on Endocrinology, Diabetes and Metabolism, Molecular Biology and Surgery. According to data from OpenAlex, León Litwak has authored 37 papers receiving a total of 642 indexed citations (citations by other indexed papers that have themselves been cited), including 32 papers in Endocrinology, Diabetes and Metabolism, 6 papers in Molecular Biology and 5 papers in Surgery. Recurrent topics in León Litwak's work include Diabetes Management and Research (19 papers), Diabetes Treatment and Management (16 papers) and Diabetes, Cardiovascular Risks, and Lipoproteins (7 papers). León Litwak is often cited by papers focused on Diabetes Management and Research (19 papers), Diabetes Treatment and Management (16 papers) and Diabetes, Cardiovascular Risks, and Lipoproteins (7 papers). León Litwak collaborates with scholars based in Argentina, United Kingdom and United States. León Litwak's co-authors include Rachid Malek, Zanariah Hussein, Mohammad E. Khamseh, Su‐Yen Goh, Pablo Knoblovits, P. Costanzo, Siddharth Shah, Pradana Soewondo, А. В. Зилов and Ole Molskov Bech and has published in prestigious journals such as SHILAP Revista de lepidopterología, PLoS ONE and Diabetes Care.

In The Last Decade

León Litwak

34 papers receiving 626 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
León Litwak Argentina 13 465 117 108 106 72 37 642
Emily G. Kurtz United States 4 397 0.9× 144 1.2× 47 0.4× 147 1.4× 22 0.3× 6 542
Takenori Sakai Japan 12 192 0.4× 52 0.4× 89 0.8× 47 0.4× 81 1.1× 41 453
F. C. W. Wu United Kingdom 7 679 1.5× 200 1.7× 44 0.4× 194 1.8× 19 0.3× 9 823
R. Townsend United Kingdom 12 244 0.5× 51 0.4× 79 0.7× 111 1.0× 64 0.9× 21 472
Mark Sader Australia 8 325 0.7× 60 0.5× 51 0.5× 80 0.8× 37 0.5× 17 635
Deborah Hinnen United States 12 809 1.7× 58 0.5× 216 2.0× 172 1.6× 63 0.9× 25 961
Charlotte Hindsberger Denmark 14 480 1.0× 241 2.1× 248 2.3× 233 2.2× 69 1.0× 23 1.0k
J Gautier France 12 226 0.5× 36 0.3× 73 0.7× 92 0.9× 90 1.3× 23 597
André Gustavo Pires de Sousa Brazil 9 125 0.3× 47 0.4× 49 0.5× 84 0.8× 35 0.5× 24 352
Lourdes Basurto Mexico 14 192 0.4× 36 0.3× 62 0.6× 126 1.2× 114 1.6× 65 619

Countries citing papers authored by León Litwak

Since Specialization
Citations

This map shows the geographic impact of León Litwak's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by León Litwak with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites León Litwak more than expected).

Fields of papers citing papers by León Litwak

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by León Litwak. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by León Litwak. The network helps show where León Litwak may publish in the future.

Co-authorship network of co-authors of León Litwak

This figure shows the co-authorship network connecting the top 25 collaborators of León Litwak. A scholar is included among the top collaborators of León Litwak based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with León Litwak. León Litwak is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Aschner, Pablo, G. R. Galstyan, Di̇lek Gogas Yavuz, et al.. (2021). Glycemic Control and Prevention of Diabetic Complications in Low- and Middle-Income Countries: An Expert Opinion. Diabetes Therapy. 12(5). 1491–1501. 14 indexed citations
2.
Cahn, Avivit, Stephen D. Wiviott, Ofri Mosenzon, et al.. (2020). 1101-P: Cardiorenal Outcomes with Dapagliflozin by Baseline Glucose Lowering Agents: Analyses from DECLARE-TIMI 58. Diabetes. 69(Supplement_1). 3 indexed citations
3.
Litwak, León, et al.. (2019). Monitoreo continuo de glucosa: Utilidad e indicaciones. Medicina-buenos Aires. 79(1). 44–52. 3 indexed citations
4.
Litwak, León. (2018). Nuevos análogos de insulina: Su utilización en pacientes con enfermedad renal crónica. Medicina-buenos Aires. 78(1). 59–61. 1 indexed citations
5.
Costanzo, P., et al.. (2013). Evaluation of the hypothalamic‐pituitary‐gonadal axis in eugonadal men with type 2 diabetes mellitus. Andrology. 2(1). 117–124. 33 indexed citations
6.
Massón, Walter, Andrea T. Kozak, Patricia Sorroche, et al.. (2013). Endocrine and inflammatory profiles in type 2 diabetic patients with and without major depressive disorder. BMC Research Notes. 6(1). 61–61. 15 indexed citations
7.
Home, Philip, et al.. (2013). Comparison of National/Regional Diabetes Guidelines for the Management of Blood Glucose Control in non-Western Countries. Diabetes Therapy. 4(1). 91–102. 25 indexed citations
8.
9.
10.
Shah, Siddharth, А. В. Зилов, Rachid Malek, et al.. (2011). Improvements in quality of life associated with insulin analogue therapies in people with type 2 diabetes: Results from the A1chieve observational study. Diabetes Research and Clinical Practice. 94(3). 364–370. 46 indexed citations
11.
Beratarrechea, Andrea, et al.. (2011). Mortality in an elderly type 2 diabetic patients’ cohort who attended a self-management educational workshop. Primary care diabetes. 5(3). 175–184. 4 indexed citations
12.
Litwak, León, et al.. (2010). Incretinas, Incretinomiméticos, Inhibidores de DPP IV: 1er parte. 47(1). 36–51.
13.
Shah, Siddharth, et al.. (2010). The A1chieve study: a 60 000-person, global, prospective, observational study of basal, meal-time, and biphasic insulin analogs in daily clinical practice. Diabetes Research and Clinical Practice. 88. S11–S16. 27 indexed citations
14.
15.
Costanzo, P., et al.. (2008). La disfunción eréctil se asocia a elevada prevalencia de obesidad y síndrome metabólico. 45(4). 142–148. 1 indexed citations
16.
Chacra, Antônio Roberto, Jaime A. Davidson, Juan Carlos Díaz, et al.. (2004). An algorithm for the treatment of type 2 diabetes in Latin America. Diabetes Obesity and Metabolism. 7(2). 148–160. 10 indexed citations
17.
18.
19.
Pekolj, Juan, et al.. (1997). Laparoscopic cholecystectomy and islet cell transplantation in a type I diabetic patient. Transplantation Proceedings. 29(4). 2089–2090. 4 indexed citations
20.
Litwak, León, et al.. (1986). Optimizing glycemic control: can insulin dependent diabetic patients rely on their perception of blood glucose fluctuations in order to make therapeutic decisions?. 3(3). 139. 3 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Emily G. Kurtz Breakdown of academic impact, for papers by Takenori Sakai Breakdown of academic impact, for papers by F. C. W. Wu Breakdown of academic impact, for papers by R. Townsend Breakdown of academic impact, for papers by Mark Sader Breakdown of academic impact, for papers by Deborah Hinnen Breakdown of academic impact, for papers by Charlotte Hindsberger Breakdown of academic impact, for papers by J Gautier Breakdown of academic impact, for papers by André Gustavo Pires de Sousa Breakdown of academic impact, for papers by Lourdes Basurto
Rankless by CCL
2026